Ward D E, Camm A J, Spurrell R A
Clin Cardiol. 1979 Jun;2(3):185-91. doi: 10.1002/clc.4960020303.
The cardiac electrophysiological effects of sotalol were studied in ten patients (pts) aged 20--65 years undergoing intracardiac stimulation studies for palpitations (7 pts) or dizzy spells (3 pts). The following measurements were made: 1. basic sinus cycle length (SCL): 2. SINUS NODE RECOVERY TIME (SNRT) following overdrive pacing; 3. intra-atrial (PA), atrio-His (AH) and His-ventricular (HV) conduction intervals during regular atrial pacing; 4. effective refractory periods of the atria (AERP), AV node (AVERP) and ventricular myocardium (VERP). AV nodal functional refractoriness (AVFRP) was also determined. All measurements were repeated 10--15 min after i.v. administration of 0.4 mg/kg of sotalol. Results were analysed by the Wilcoxon Signed Rank test. Significant increases in SCL (p less than 0.01), AH (p less than 0.01). SNRT (p less than 0.01), AVERP (p less than 0.02) and AVFRP (p less than 0.01) were observed. These effects are consistent with the beta-blocking action of sotalol. The acute increase in AERP (p less than 0.01) is, however, not a common property of other beta-blockers and may be related to the 'class III' cellular effect of sotalol. These results are discussed in relationship to the electrophysiological effects of other beta-blocking drugs.
对10例年龄在20至65岁因心悸(7例)或眩晕(3例)而接受心内刺激研究的患者,研究了索他洛尔的心脏电生理效应。进行了以下测量:1. 基础窦性周期长度(SCL);2. 超速起搏后的窦房结恢复时间(SNRT);3. 常规心房起搏期间的房内(PA)、房室(AH)和希氏束-心室(HV)传导间期;4. 心房(AERP)、房室结(AVERP)和心室肌(VERP)的有效不应期。还测定了房室结功能不应期(AVFRP)。静脉注射0.4mg/kg索他洛尔10至15分钟后,重复所有测量。结果采用Wilcoxon符号秩检验进行分析。观察到SCL(p<0.01)、AH(p<0.01)、SNRT(p<0.01)、AVERP(p<0.02)和AVFRP(p<0.01)有显著增加。这些效应与索他洛尔的β受体阻滞作用一致。然而,AERP的急性增加(p<0.01)并非其他β受体阻滞剂的共同特性,可能与索他洛尔的“Ⅲ类”细胞效应有关。结合其他β受体阻滞药物的电生理效应讨论了这些结果。